Drugs / VagiBIOM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05060029 | Jan → Aug 2022 | bacterial vaginosis | Vedic Lifesciences Pvt. Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VagiBIOM | “In this study, the safety and efficacy of the vaginal suppository VagiBIOM will be studied in aging women with BV infection.” NCT05060029 ↗ |
| Modality | Other / unclassified | “a multi-Lactobacillus vaginal suppository” PMID 38336815 ↗ Feb 2024 |
| Route | Other | “the vaginal suppository VagiBIOM” NCT05060029 ↗ |